An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)

S. Cunningham (Edinburgh, United Kingdom), C. Graham (Edinburgh, United Kingdom), M. Maclean (Edinburgh, United Kingdom), P. Aurora (London, United Kingdom), M. Ashworth (London, United Kingdom), A. Calder (London, United Kingdom), A. Clement (Paris, France), M. Hengste (Munich, Germany), N. Kiper (Ankara, Turkey), K. Krenke (Warzaw, Poland), J. Lange (Warzaw, Poland), A. Nicholson (London, United Kingdom), S. Reu (Munich, Germany), D. Snijders (Padua, Italy), A. Bush (London, United Kingdom), N. Schwerk (Hannover, Germany), M. Griese (Munich, Germany)

Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Session: Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Session type: Poster Discussion
Number: 5027
Disease area: Interstitial lung diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Cunningham (Edinburgh, United Kingdom), C. Graham (Edinburgh, United Kingdom), M. Maclean (Edinburgh, United Kingdom), P. Aurora (London, United Kingdom), M. Ashworth (London, United Kingdom), A. Calder (London, United Kingdom), A. Clement (Paris, France), M. Hengste (Munich, Germany), N. Kiper (Ankara, Turkey), K. Krenke (Warzaw, Poland), J. Lange (Warzaw, Poland), A. Nicholson (London, United Kingdom), S. Reu (Munich, Germany), D. Snijders (Padua, Italy), A. Bush (London, United Kingdom), N. Schwerk (Hannover, Germany), M. Griese (Munich, Germany). An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU). 5027

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Diffuse interstitial lung disease (a retrospective analysis of 79 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002

Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021



Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Retrospective analysis of 280 patients with diffuse parenchymal lung diseases (DPLDs)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


CF disease progress regarding lung symptoms – a cohort study
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


A retrospective cohort study of interstitial lung diseases in Denmark
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Frequency and characterization of sleep related disorders in interstitial lung disease patients: a prospective study
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Early symptoms in suspected lung cancer: a prospective cohort study
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

A single-centre retrospective study to phenotype unclassifiable interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020